Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat

S. Huang, X. Guan (Guangzhou, China)

Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Session: Severe sepsis and multiple organ failure
Session type: Oral Presentation
Number: 2801

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Huang, X. Guan (Guangzhou, China). Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat. Eur Respir J 2009; 34: Suppl. 53, 2801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CD101 eosinophil serves as an early response to suppress endotoxin-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018


Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011

Immunotherapy improves inflammatory cytokines, humoral immunity and cellular immunity in septic patients
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010


Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019


Monocyte inflammatory responsiveness and potential therapeutic target for pigeon fancier‘s hypersensitivity pneumonitis (HP)
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012

Role of altered immune response in CF and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


Successful treatment of lung inflammation is associated with elevation of lymphocyte sensitivity to glucocorticoids
Source: Eur Respir J 2001; 18: Suppl. 33, 433s
Year: 2001

Targeting AMPK and the Nrf2/HO-1 axis: a promising therapeutic strategy in acute lung injury
Source: Eur Respir J, 58 (6) 2102238; 10.1183/13993003.02238-2021
Year: 2021



Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
Source: Annual Congress 2011 - T-cell subsets
Year: 2011

Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005


From ineffective tumor immune response to immunomodulation in lung cancer
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017


The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019



The role of pro-inflammatory cytokine activation in perioperative lung injury
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004

Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses.
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Tim-3 regulates Tregs’ ability to resolve the inflammation and proliferation of acute lung injury by polarizing M2c macrophages
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Therapeutic potential of mesenchymal stem cells to attenuate immune cell tolerance in a late stage model of sepsis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008